Compounding Pharmacy Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Compounding Pharmacy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.4% during the forecast period.

    This report presents the market size and development trends by detailing the Compounding Pharmacy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Compounding Pharmacy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Compounding Pharmacy industry and will help you to build a panoramic view of the industrial development.

    Compounding Pharmacy Market, By Type:

    • Pharmaceutical Ingredient Alteration (PIA)

    • Pharmaceutical Application Alteration (PAA)

    • Currently Unavailable Pharmaceutical Manufacturing (CUPM)

    • Pharmaceutical Dosage Alteration (PDA)

    • Specialized Animal Pharmaceutical Manufacturing (SAPM)

    Compounding Pharmacy Market, By Application:

    • 18 and Younger

    • 19 to 44

    • 45 to 64

    • 65 and Older

    Some of the leading players are as follows:

    • Lorraine's Pharmacy

    • PharMEDium Services

    • Institutional Pharmacy Solutions

    • Dougherty’s Pharmacy

    • Triangle Compounding Pharmacy

    • Cantrell Drug

    • Fagron

    • Olympia Pharmacy

    • CAPS

    • Village Compounding Pharmacy

    • Fresenius Kabi

    • Wedgewood Pharmacy

    • Advanced Pharma

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Compounding Pharmacy Market: Technology Type Analysis

    • 4.1 Compounding Pharmacy Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Compounding Pharmacy Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Pharmaceutical Ingredient Alteration (PIA)

      • 4.3.2 Pharmaceutical Application Alteration (PAA)

      • 4.3.3 Currently Unavailable Pharmaceutical Manufacturing (CUPM)

      • 4.3.4 Pharmaceutical Dosage Alteration (PDA)

      • 4.3.5 Specialized Animal Pharmaceutical Manufacturing (SAPM)

    5 Compounding Pharmacy Market: Product Analysis

    • 5.1 Compounding Pharmacy Product Market Share Analysis, 2018 & 2026

    • 5.2 Compounding Pharmacy Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Compounding Pharmacy Market: Application Analysis

    • 6.1 Compounding Pharmacy Application Market Share Analysis, 2018 & 2026

    • 6.2 Compounding Pharmacy Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 18 and Younger

      • 6.3.2 19 to 44

      • 6.3.3 45 to 64

      • 6.3.4 65 and Older

    7 Compounding Pharmacy Market: Regional Analysis

    • 7.1 Compounding Pharmacy Regional Market Share Analysis, 2018 & 2026

    • 7.2 Compounding Pharmacy Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Lorraine's Pharmacy

      • 9.1.1 Lorraine's Pharmacy Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 PharMEDium Services

      • 9.2.1 PharMEDium Services Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Institutional Pharmacy Solutions

      • 9.3.1 Institutional Pharmacy Solutions Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Dougherty’s Pharmacy

      • 9.4.1 Dougherty’s Pharmacy Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Triangle Compounding Pharmacy

      • 9.5.1 Triangle Compounding Pharmacy Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Cantrell Drug

      • 9.6.1 Cantrell Drug Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Fagron

      • 9.7.1 Fagron Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Olympia Pharmacy

      • 9.8.1 Olympia Pharmacy Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 CAPS

      • 9.9.1 CAPS Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Village Compounding Pharmacy

      • 9.10.1 Village Compounding Pharmacy Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Fresenius Kabi

      • 9.11.1 Fresenius Kabi Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Wedgewood Pharmacy

      • 9.12.1 Wedgewood Pharmacy Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Advanced Pharma

      • 9.13.1 Advanced Pharma Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

     

    The List of Tables and Figures (Totals 62 Figures and 133 Tables)

    • Figure Pharmaceutical Ingredient Alteration (PIA) Compounding Pharmacy market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Application Alteration (PAA) Compounding Pharmacy market, 2015 - 2026 (USD Million)

    • Figure Currently Unavailable Pharmaceutical Manufacturing (CUPM) Compounding Pharmacy market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Dosage Alteration (PDA) Compounding Pharmacy market, 2015 - 2026 (USD Million)

    • Figure Specialized Animal Pharmaceutical Manufacturing (SAPM) Compounding Pharmacy market, 2015 - 2026 (USD Million)

    • Figure 18 and Younger market, 2015 - 2026 (USD Million)

    • Figure 19 to 44 market, 2015 - 2026 (USD Million)

    • Figure 45 to 64 market, 2015 - 2026 (USD Million)

    • Figure 65 and Older market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

    • Table North America Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table North America Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table North America Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Canada Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Canada Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Europe Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

    • Table Europe Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Europe Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Europe Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Germany Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Germany Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table France Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table France Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Italy Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Italy Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Spain Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Spain Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table China Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table China Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Japan Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Japan Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table India Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table India Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table MEA Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

    • Table MEA Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table MEA Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table MEA Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Lorraine's Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table PharMEDium Services Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Institutional Pharmacy Solutions Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Dougherty’s Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Triangle Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cantrell Drug Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fagron Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Olympia Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CAPS Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Village Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fresenius Kabi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Wedgewood Pharmacy Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Advanced Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.